A randomized, open-label, active-controlled, multicenter, parallel group study to assess the efficacy, safety and tolerability of topical 10 % terbinafine hydrogen chloride (HCI) formulation versus 5% amorolfine nail lacquer for 48 weeks of treatment in patients wiht mild to moderate toenail onychomycosis